GR3033783T3 - Method for treating anxiety using an azabicyclic oxadiazole or thiadiazole compound - Google Patents

Method for treating anxiety using an azabicyclic oxadiazole or thiadiazole compound

Info

Publication number
GR3033783T3
GR3033783T3 GR20000401482T GR20000401482T GR3033783T3 GR 3033783 T3 GR3033783 T3 GR 3033783T3 GR 20000401482 T GR20000401482 T GR 20000401482T GR 20000401482 T GR20000401482 T GR 20000401482T GR 3033783 T3 GR3033783 T3 GR 3033783T3
Authority
GR
Greece
Prior art keywords
branched
straight
alkyl
phenyl
alkynyl
Prior art date
Application number
GR20000401482T
Other languages
English (en)
Inventor
Neil Clayton Bodick
Franklin Porter Bymaster
Walter William Offen
Harlan Edgar Shannon
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/332,186 external-priority patent/US5488056A/en
Priority claimed from US08/336,589 external-priority patent/US5484794A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of GR3033783T3 publication Critical patent/GR3033783T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
GR20000401482T 1994-10-31 2000-06-27 Method for treating anxiety using an azabicyclic oxadiazole or thiadiazole compound GR3033783T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/332,186 US5488056A (en) 1994-10-31 1994-10-31 Method for treating anxiety
US08/336,589 US5484794A (en) 1994-11-09 1994-11-09 Method for treating anxiety

Publications (1)

Publication Number Publication Date
GR3033783T3 true GR3033783T3 (en) 2000-10-31

Family

ID=26988105

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000401482T GR3033783T3 (en) 1994-10-31 2000-06-27 Method for treating anxiety using an azabicyclic oxadiazole or thiadiazole compound

Country Status (13)

Country Link
US (1) US5726193A (el)
EP (1) EP0709093B1 (el)
JP (1) JPH10508027A (el)
AT (1) ATE191343T1 (el)
AU (1) AU4017295A (el)
CA (1) CA2202781A1 (el)
DE (1) DE69516075T2 (el)
DK (1) DK0709093T3 (el)
ES (1) ES2144582T3 (el)
GR (1) GR3033783T3 (el)
IL (1) IL115810A0 (el)
PT (1) PT709093E (el)
WO (1) WO1996013166A1 (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763457A (en) * 1995-11-13 1998-06-09 Eli Lilly And Company Method for treating anxiety
US5852037A (en) * 1995-11-13 1998-12-22 Eli Lilly And Company Method for treating anxiety
AU1128297A (en) * 1995-12-06 1997-06-27 Eli Lilly And Company Composition for treating pain
US6391922B1 (en) 1998-01-13 2002-05-21 Synchroneuron, Llc Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders
US8461389B2 (en) 2008-04-18 2013-06-11 University College Dublin, National University Of Ireland, Dublin Psycho-pharmaceuticals

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83275A (en) * 1986-09-08 1994-02-27 Novo Nordisk As Compounds 1,2, 4-Oxadiazolyl Pipridine Transformed, their preparation and pharmaceutical preparations containing them
NZ227841A (en) * 1988-02-12 1991-08-27 Merck Sharp & Dohme Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
DK198390D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5418240A (en) * 1990-08-21 1995-05-23 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
DK198490D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5330994A (en) * 1992-03-24 1994-07-19 Warner-Lambert Company Tetrahydropyridine isoxazoline derivatives
NZ336596A (en) * 1993-08-19 2001-02-23 Novo Nordisk As Oxa or thia-diazole substituted azabicyclic ring compounds for treating schizophreniform diseases
DE69430816T2 (de) * 1993-08-19 2002-12-19 Novo Nordisk As Verwendung von Piperidin-Derivaten in der Behandlung von Schizophrenie

Also Published As

Publication number Publication date
DK0709093T3 (da) 2000-07-10
ES2144582T3 (es) 2000-06-16
AU4017295A (en) 1996-05-23
PT709093E (pt) 2000-08-31
CA2202781A1 (en) 1996-05-09
EP0709093A3 (el) 1996-05-29
US5726193A (en) 1998-03-10
EP0709093A2 (en) 1996-05-01
ATE191343T1 (de) 2000-04-15
EP0709093B1 (en) 2000-04-05
DE69516075T2 (de) 2000-09-14
JPH10508027A (ja) 1998-08-04
IL115810A0 (en) 1996-01-19
DE69516075D1 (de) 2000-05-11
WO1996013166A1 (en) 1996-05-09

Similar Documents

Publication Publication Date Title
ES8401486A1 (es) Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina.
NO169286C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolin-2-okso-1-karboksylsyrederivater
HUP0204246A2 (hu) Új tiazolo[4,5-d]pirimidin-származékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
DE69516076T2 (de) Tetrahydropyridin Oxadiazol- oder -Thiadiazol-Verbindung zur Behandlung von Angstzuständen
EP1411052A4 (en) BENZO-CONDENSED 5-CHAIN HETEROCYCLE COMPOUNDS, PROCESS FOR PREPARING SAME AND USE THEREOF
CA2136553A1 (en) 7-(2-aminoethyl)-Benzothiazolones
GR3033783T3 (en) Method for treating anxiety using an azabicyclic oxadiazole or thiadiazole compound
CA2169838A1 (en) Antipsychotic method
NO168890C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive acylcephalosporinderivater
PT85008A (en) Process for the preparation of 2-thiazolil-imidazo ]1,2-c" pyrimidines of their salts of acid addition and of pharmaceutical composicoes containing them
CU21554A3 (en) Obtainment procedure of imidazobenzodiacepine
AU1060592A (en) N-(aryloxyalkyl)heteroaryl-8-azabicyclo(3,2,1)octanes, intermediates and a process for the preparation thereof and their use as medicaments
GB9209330D0 (en) Chemical compounds
ES8707951A1 (es) Derivados de tetrazol
NO861868L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatian-derivater.
MY103825A (en) Novel basic-substituted 5-halo-thienoisothiazol-3(2h)- one 1, 1-dioxides, a process for the preparation thereof, and pharmaceutical preparation containing these compounds
ES8802507A1 (es) Procedimiento para preparar eteres 1,3-dioxano.
MX9701252A (es) Derivados de diarilalcano que contienen un grupo aliciclico, su preparacion y sus usos terapeutico y profilactico.
ATE208761T1 (de) Quinolin-derivate und diese enthaltende pharmazeutische zusammensetzungen
ES2005778A6 (es) Procedimiento para la obtencion de derivados de diisobutilxantina.
CO4910157A1 (es) Derivados de vinilpirrolidinos-cefalosporina

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees